Next Generation Meds Offer New Options for Myeloma Patients
Topic Areas:
Multiple Myeloma
View next
Next generation of medicines are helping even the sickest patients with multiple myeloma live longer and better. In this video, Dr. Jesús San Miguel discusses some new information about a new immunomodulator drug that is proving effective for some patients who were no longer responding to standard treatments. He also talks about another drug class, monoclonal antibodies, that are also showing promise in resistant disease.
